Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs)

被引:66
作者
Kim, Jong Min
Lee, Yun Mi
Lee, Ga Young
Jang, Dae Sik
Bae, Ki Hwan
Kim, Jin Sook
机构
[1] Korea Inst Oriental Med, Dept Herbal Pharmaceut Dev, Taejon 305811, South Korea
[2] Chungnam Natl Univ, Coll Pharm, Taejon 305764, South Korea
关键词
Pueraria lobata; Leguminosae; puerarin; PG-3; (+/-)-puerol B; advanced glycation end products (AGEs); diabetic complications;
D O I
10.1007/BF02973900
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Two isoflavone C-glucosides, puerarin (1) and PG-3 (2), a but-2-enolide, (+/-)-puerol B (3), two isoflavone O-glucosides, daidzin (4) and genistin (5), and three pterocarpans, (-)-medicarpin (6), (-)-glycinol (7) and (-)-tuberosin (8), were isolated from a MeOH extract of the roots of Pueraria lobata, using an in vitro bioassay based on the inhibition of the formation of advanced glycation end products (AGEs) to monitor chromatographic fractionation. The structures of 1-8 were determined by spectroscopic data interpretation, particularly by 1D- and 2D-NMR studies, and by comparison of these data with values in the literature. All of the isolates (1-8) were evaluated for their inhibitory activity on AGEs formation in vitro. Of these, puerarin (1), PG-3 (2), and (+/-)-puerol B (3) exhibited more potent inhibitory activity than the positive control aminoguanidine.
引用
收藏
页码:821 / 825
页数:5
相关论文
共 20 条
[1]
Bae KH., 2000, MED PLANTS KOREA, P260
[2]
Advanced glycosylation end products in diabetic renal and vascular disease [J].
Bucala, R ;
Vlassara, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (06) :875-888
[3]
Role of advanced glycation end products in diabetic nephropathy [J].
Forbes, JM ;
Cooper, ME ;
Oldfield, MD ;
Thomas, MC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 :S254-S258
[4]
Advanced glycation end products in clinical nephrology [J].
Kalousová, M ;
Zima, T ;
Tesar, V ;
Stípek, S ;
Sulková, S .
KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (01) :18-28
[5]
Kim JinSook, 2002, Korean Journal of Pharmacognosy, V33, P308
[6]
KINJO JE, 1987, CHEM PHARM BULL, V35, P4846
[7]
THE LINK BETWEEN HYPERGLYCEMIA AND DIABETIC NEPHROPATHY [J].
LARKINS, RG ;
DUNLOP, ME .
DIABETOLOGIA, 1992, 35 (06) :499-504
[8]
Lee Song Jin, 1994, Archives of Pharmacal Research (Seoul), V17, P31, DOI 10.1007/BF02978244
[9]
LYNE RL, 1978, TETRAHEDRON LETT, P3127
[10]
ADVANCED GLYCOSYLATION END-PRODUCTS IN PATIENTS WITH DIABETIC NEPHROPATHY [J].
MAKITA, Z ;
RADOFF, S ;
RAYFIELD, EJ ;
YANG, Z ;
SKOLNIK, E ;
DELANEY, V ;
FRIEDMAN, EA ;
CERAMI, A ;
VLASSARA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) :836-842